Research Article
Clinical and Functional Characteristics of Subjects with Asthma, COPD, and Asthma-COPD Overlap: A Multicentre Study in Vietnam
Table 4
Probability of risk factors for asthma, COPD, and ACO.
| | Parameters | Odds ratio (CI 95% odds ratio), | | Asthma | COPD | ACO |
| | Childhood asthma | 27.0 (4.6–49.7)
| −27.0 (4.6–49.7)
| 4.8 (0.9–17.2)
| | Chronic bronchitis | −17.0 (3.5–37.9)
| 17.0 (3.5–37.9)
| 3.7 (1.0–8.2)
| | Allergy status | 32.1 (5.7–58.2)
| −32.1 (5.7–58.2)
| 17.2 (3.5–35.4)
| | Cough + expectoration | −27.2 (4.5–51.9)
| 27.2 (4.5–51.9)
| 17.5 (3.8–40.3)
| | Dyspnea crisis | 26.8 (5.2–47.8)
| −26.8 (5.2–47.8)
| 1.6 (0.5–3.7)
| | Effort-induced dyspnea | −16.4 (7.2–30.7)
| 16.4 (7.2–30.7)
| 29.8 (9.8–48.9)
| | Hypereosinophilia | 28.4 (9.4–48.6)
| −28.4 (9.4–48.6)
| 16.2 (5.6–30.6)
| | Increased CRP | −11.5 (3.7–19.4)
| 11.5 (3.7–19.4)
| 1.7 (0.7–3.8)
| | Increased total IgE | 15.9 (6.1–31.4)
| −15.9 (6.1–31.4)
| 2.7 (1.2–5.9)
| | Increased FENO | 32.5 (12.6–50.5)
| −32.5 (12.6–50.5)
| 18.3 (6.9–32.7)
| | Increased CANO | −29.1 (10.2–46.7)
| −33.2 (12.3–54.8)
| 33.2 (12.3–54.8)
| | AHI > 15 | −3.4 (1.3–9.9)
| −3.1 (1.2–8.6)
| 3.4 (1.3–9.9)
|
|
|
ACO: asthma-COPD overlap; asthma versus COPD; COPD versus asthma; ACO versus COPD; ACO versus asthma; asthma versus ACO; COPD versus ACO. |
